Valérie Perrot

1.2k total citations
56 papers, 946 citations indexed

About

Valérie Perrot is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Valérie Perrot has authored 56 papers receiving a total of 946 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 18 papers in Molecular Biology and 16 papers in Cancer Research. Recurrent topics in Valérie Perrot's work include Renal cell carcinoma treatment (20 papers), Cancer Genomics and Diagnostics (14 papers) and Economic and Financial Impacts of Cancer (12 papers). Valérie Perrot is often cited by papers focused on Renal cell carcinoma treatment (20 papers), Cancer Genomics and Diagnostics (14 papers) and Economic and Financial Impacts of Cancer (12 papers). Valérie Perrot collaborates with scholars based in France, United States and Germany. Valérie Perrot's co-authors include Matthew M. Rechler, J. Silvio Gutkind, José Vázquez‐Prado, Bruria Funkenstein, Shu Jin Chan, Yehoshua Gozes, P.M. Ingleton, Jérôme Honnorat, Jun Nakae and Véronique Rogemond and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Journal of Neuroscience.

In The Last Decade

Valérie Perrot

49 papers receiving 930 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Valérie Perrot France 16 443 214 167 165 137 56 946
Ning‐Ai Liu United States 19 588 1.3× 73 0.3× 417 2.5× 267 1.6× 147 1.1× 29 1.2k
Grant G. Kelley United States 21 1.3k 3.0× 208 1.0× 287 1.7× 211 1.3× 139 1.0× 32 1.7k
K. Tanzawa Japan 12 504 1.1× 115 0.5× 100 0.6× 55 0.3× 49 0.4× 18 1.1k
Olov Andersson Sweden 22 1.1k 2.5× 45 0.2× 251 1.5× 158 1.0× 329 2.4× 45 1.7k
Emil Karaulanov Germany 17 1.3k 3.0× 124 0.6× 216 1.3× 132 0.8× 176 1.3× 25 1.7k
Germano Gaudenzi Italy 18 516 1.2× 104 0.5× 148 0.9× 145 0.9× 70 0.5× 42 933
Patrizia Porazzi United States 16 478 1.1× 20 0.1× 85 0.5× 139 0.8× 143 1.0× 30 862
Sonal Brahmbhatt Canada 10 433 1.0× 140 0.7× 151 0.9× 25 0.2× 92 0.7× 10 974
Carlos O. Lizama United States 19 548 1.2× 101 0.5× 162 1.0× 26 0.2× 99 0.7× 45 1.2k
Yoshihide Ikebuchi Japan 17 453 1.0× 72 0.3× 217 1.3× 25 0.2× 73 0.5× 21 853

Countries citing papers authored by Valérie Perrot

Since Specialization
Citations

This map shows the geographic impact of Valérie Perrot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Valérie Perrot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Valérie Perrot more than expected).

Fields of papers citing papers by Valérie Perrot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Valérie Perrot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Valérie Perrot. The network helps show where Valérie Perrot may publish in the future.

Co-authorship network of co-authors of Valérie Perrot

This figure shows the co-authorship network connecting the top 25 collaborators of Valérie Perrot. A scholar is included among the top collaborators of Valérie Perrot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Valérie Perrot. Valérie Perrot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thibault, Constance, Loı̈c Mourey, Dominique Pasquier, et al.. (2025). OCTOPUS: A retrospective, multicenter study of real-world cabozantinib treatment of patients with advanced renal cell carcinoma in France—Subgroup analyses of treatment sequences and optimization.. Journal of Clinical Oncology. 43(5_suppl). 472–472. 1 indexed citations
2.
Ramon‐Krauel, Marta, Michel Polak, Mohamad Maghnie, et al.. (2025). Near-Adult Height Outcomes in Patients Treated With rhIGF-1 for Severe Growth Failure: Real-World IGFD Registry Data. The Journal of Clinical Endocrinology & Metabolism. 111(2). e500–e511. 1 indexed citations
3.
4.
Nathan, Paul, Jennifer Allison, Natalie Charnley, et al.. (2024). Real-world Treatment Sequencing and Outcomes With Cabozantinib After First-line Immune Checkpoint Inhibitor-based Combination Therapy For Patients With Advanced Renal Cell Carcinoma: CARINA Study Results. Clinical Genitourinary Cancer. 22(5). 102141–102141. 1 indexed citations
5.
Créhange, G., et al.. (2023). PO-1479 Management of androgen deprivation therapy (ADT) by French radiation oncologists, TALISMAN study. Radiotherapy and Oncology. 182. S1198–S1198.
6.
Bang, Peter, Michel Polak, Artur Bossowski, et al.. (2023). Frequency and Predictive Factors of Hypoglycemia in Patients Treated With rhIGF-1: Data From the Eu-IGFD Registry. The Journal of Clinical Endocrinology & Metabolism. 109(1). 46–56. 4 indexed citations
7.
Nathan, Paul, Jennifer Allison, Natalie Charnley, et al.. (2023). Real-world treatment sequencing and outcomes for patients with advanced renal cell carcinoma treated with cabozantinib after first-line checkpoint inhibitor-based combination therapy: Results from the CARINA study.. Journal of Clinical Oncology. 41(16_suppl). e16512–e16512. 2 indexed citations
8.
Thiery-Vuillemin, Antoine, et al.. (2023). Main reasons of choice of formulation and route of triptorelin treatment initiated in patients with prostate cancer (PCa): TALISMAN study.. Journal of Clinical Oncology. 41(6_suppl). 104–104.
9.
Venugopal, Balaji, Manon Pillai, Thomas Powles, et al.. (2021). Early Clinical Experience with Cabozantinib for Advanced Renal Cell Carcinoma in the UK: Real-World Treatment Pathways and Clinical Outcomes. Clinical Genitourinary Cancer. 20(1). 94–94.e10. 6 indexed citations
10.
11.
Gross‐Goupil, Marine, Aude Fléchon, Loı̈c Mourey, et al.. (2021). 670P Cabozantinib associated with concomitant radiotherapy or a bone targeted agent (multimodal approach, results from the CABOREAL study post-hoc analysis). Annals of Oncology. 32. S694–S695. 1 indexed citations
12.
Gross‐Goupil, Marine, Aude Fléchon, Loı̈c Mourey, et al.. (2020). 722P Cabozantinib in elderly patients: Results from a subanalysis of the CABOREAL study. Annals of Oncology. 31. S566–S567. 4 indexed citations
13.
Procopio, Giuseppe, Paul Hamberg, Pierre Bigot, et al.. (2020). 730P Interim analysis of CASSIOPE: A real-world study of cabozantinib for the treatment of advanced renal cell carcinoma (aRCC) after VEGF-targeted therapy in Europe. Annals of Oncology. 31. S571–S571. 1 indexed citations
14.
15.
Brot, Sébastien, Véronique Rogemond, Valérie Perrot, et al.. (2010). CRMP5 Interacts with Tubulin to Inhibit Neurite Outgrowth, Thereby Modulating the Function of CRMP2. Journal of Neuroscience. 30(32). 10639–10654. 55 indexed citations
16.
Durual, Stéphane, Carine Blanchard, Monique Estienne, et al.. (2005). Expression of human TFF3 in relation to growth of HT-29 cell subpopulations: involvement of PI3-K but not STAT6. Differentiation. 73(1). 36–44. 16 indexed citations
17.
18.
Perrot, Valérie, José Vázquez‐Prado, & J. Silvio Gutkind. (2002). Plexin B Regulates Rho through the Guanine Nucleotide Exchange Factors Leukemia-associated Rho GEF (LARG) and PDZ-RhoGEF. Journal of Biological Chemistry. 277(45). 43115–43120. 184 indexed citations
19.
Tomizawa, M., Amit Kumar, Valérie Perrot, et al.. (2000). Insulin Inhibits the Activation of Transcription by a C-terminal Fragment of the Forkhead Transcription Factor FKHR. Journal of Biological Chemistry. 275(10). 7289–7295. 60 indexed citations
20.
Perrot, Valérie, et al.. (1999). Ontogeny of the Insulin-like Growth Factor System (IGF-I, IGF-II, and IGF-1R) in Gilthead Seabream (Sparus aurata): Expression and Cellular Localization. General and Comparative Endocrinology. 116(3). 445–460. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ning‐Ai Liu Breakdown of academic impact, for papers by Grant G. Kelley Breakdown of academic impact, for papers by K. Tanzawa Breakdown of academic impact, for papers by Olov Andersson Breakdown of academic impact, for papers by Emil Karaulanov Breakdown of academic impact, for papers by Germano Gaudenzi Breakdown of academic impact, for papers by Patrizia Porazzi Breakdown of academic impact, for papers by Sonal Brahmbhatt Breakdown of academic impact, for papers by Carlos O. Lizama Breakdown of academic impact, for papers by Yoshihide Ikebuchi
Rankless by CCL
2026